Article Details
Retrieved on: 2024-04-04 19:01:11
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses migraine's significant global health impact, with Pfizer Canada's release of NURTEC ODT (rimegepant) in Canada to address this disability by targeting neurogenic inflammation and CGRP related to migraines.
Article found on: finance.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here